Cargando…

Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion

Malignant pleural effusion (MPE) is common in lung cancer. We report a case of highly viscous recurrent MPE associated with lung cancer. The viscosity prohibited gravity-dependent drainage initially with a 6-Fr aspiration catheter and subsequently with a 12-Fr intercostal drain. The effusion was eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Foo, Chuan Tai, Herre, Jurgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077594/
https://www.ncbi.nlm.nih.gov/pubmed/33976621
http://dx.doi.org/10.1159/000515077
_version_ 1783684908098519040
author Foo, Chuan Tai
Herre, Jurgen
author_facet Foo, Chuan Tai
Herre, Jurgen
author_sort Foo, Chuan Tai
collection PubMed
description Malignant pleural effusion (MPE) is common in lung cancer. We report a case of highly viscous recurrent MPE associated with lung cancer. The viscosity prohibited gravity-dependent drainage initially with a 6-Fr aspiration catheter and subsequently with a 12-Fr intercostal drain. The effusion was eventually evacuated after a single dose of intrapleural fibrinolytic therapy. This process was repeated a total of 13 times over a 12-month period in an ambulatory setting. No bleeding complications were observed. This case highlights the feasibility and safety of repeated intrapleural fibrinolysis in the management of highly viscous recurrent MPE in an ambulatory setting.
format Online
Article
Text
id pubmed-8077594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-80775942021-05-10 Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion Foo, Chuan Tai Herre, Jurgen Case Rep Oncol Case Report Malignant pleural effusion (MPE) is common in lung cancer. We report a case of highly viscous recurrent MPE associated with lung cancer. The viscosity prohibited gravity-dependent drainage initially with a 6-Fr aspiration catheter and subsequently with a 12-Fr intercostal drain. The effusion was eventually evacuated after a single dose of intrapleural fibrinolytic therapy. This process was repeated a total of 13 times over a 12-month period in an ambulatory setting. No bleeding complications were observed. This case highlights the feasibility and safety of repeated intrapleural fibrinolysis in the management of highly viscous recurrent MPE in an ambulatory setting. S. Karger AG 2021-03-16 /pmc/articles/PMC8077594/ /pubmed/33976621 http://dx.doi.org/10.1159/000515077 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Foo, Chuan Tai
Herre, Jurgen
Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title_full Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title_fullStr Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title_full_unstemmed Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title_short Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
title_sort ambulatory intrapleural fibrinolytic therapy in highly viscous recurrent malignant pleural effusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077594/
https://www.ncbi.nlm.nih.gov/pubmed/33976621
http://dx.doi.org/10.1159/000515077
work_keys_str_mv AT foochuantai ambulatoryintrapleuralfibrinolytictherapyinhighlyviscousrecurrentmalignantpleuraleffusion
AT herrejurgen ambulatoryintrapleuralfibrinolytictherapyinhighlyviscousrecurrentmalignantpleuraleffusion